Investor's Business Daily: HEALTH
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
Biotech Could Follow Pharma's M&A Lead
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Much of the drug industry's attention has recently focused on mergers and acquisitions by the biggest of Big Pharma, including much-hyped unions...
Source: Investor's Business Daily: HEALTH - March 25, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Mergers Bring New Challenges To PharmaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pharma's urge to merge has seen a surge. Merck (MRK) and Schering-Plough (SGP), Pfizer (PFE) and Wyeth (WYE), RocheRHHBY and Genentech (DNA) --...
Source: Investor's Business Daily: HEALTH - March 14, 2009 Category: Pharmaceuticals Tags: Health & Medicine PFE MRK DNA WYE SGP Source Type: info
Astellas Quiet After Gilead Bid For CVEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Astellas Pharma, Japan's second-largest drugmaker, said on Friday it had not decided how to respond after takeover target CV Therapeutics agreed...
Source: Investor's Business Daily: HEALTH - March 13, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Astellas Continues Assault On CV BoardEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Japan's Astellas Pharma on Friday said it would nominate two directors for election to the board of CV Therapeutics after the U.S. biotech...
Source: Investor's Business Daily: HEALTH - March 11, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Roche Ups The Ante In Bid For GenentechEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
It looks like Roche Holdings was the first to blink in its months-long takeover battle with Genentech.
Source: Investor's Business Daily: HEALTH - March 7, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Cephalon Launches Bid For Aussie BiotechEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Shares of Cephalon retreated early Friday after the biotechnology company launched a takeover bid valued at $207 million for Australian biotech...
Source: Investor's Business Daily: HEALTH - March 3, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Vertex Exec Change May Be One Of ManyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Chemist Joshua Boger founded Vertex Pharmaceuticals 20 years ago. For months, he was its only employee.
Source: Investor's Business Daily: HEALTH - February 28, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
MedTech Sector Gains From Stimulus PlanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The campaign for a nationwide electronic medical records system got a needed boost last week when President Obama signed into law the American...
Source: Investor's Business Daily: HEALTH - February 21, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
WellCare To Suspend Medicare EnrollmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Shares of WellCare Health Plans fell more than 20% early Friday after the insurer said it will suspend marketing and enrollment for its Medicare...
Source: Investor's Business Daily: HEALTH - February 20, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Thoratec Acquires Maker Of Heart PumpsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Cardiac device maker Thoratec on Friday said it would buy Australian heart-pump maker HeartWare International for about $282 million in a cash and...
Source: Investor's Business Daily: HEALTH - February 19, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
P&G's Plan To Divest Follows Sector TrendEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Divesting has become the flavor of the decade in the pharmaceutical world.
Source: Investor's Business Daily: HEALTH - February 14, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Weak Tysabri Sales Hurt Biogen ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Biogen Idec beat fourth-quarter earnings views Friday with a 3% gain, though sales of its multiple sclerosis drug Tysabri fell short of...
Source: Investor's Business Daily: HEALTH - February 12, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Stem Cell Companies See Signs Of HopeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Though the Obama administration will lift Bush-era restrictions on use of federal funds for research into embryonic stem cells, it's probably too...
Source: Investor's Business Daily: HEALTH - February 7, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Roche Makes Hostile Bid For GenentechEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Swiss drugmaker Roche Holding went hostile in its bid to buy U.S. biotech Genentech on Friday by offering $86.50 a share — $2.50 less...
Source: Investor's Business Daily: HEALTH - February 5, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Pfizer Buy Of Wyeth Has A Familiar LookEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
It's not as if Pfizer is breaking new ground with its $68 billion cash-and-stock bid for Wyeth, which was announced to great fanfare last week...
Source: Investor's Business Daily: HEALTH - January 31, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Roche Makes Hostile Bid For GenentechEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Swiss drugmaker Roche Holding went hostile in its bid to buy U.S. biotech Genentech on Friday by offering $86.50 a share — $2.50 less...
Source: Investor's Business Daily: HEALTH - January 30, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
FDA OKs Human Stem Cell Therapy TestEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Food and Drug Administration on Friday cleared the way for the first trial to see if human embryonic stem cells can treat people safely.
Source: Investor's Business Daily: HEALTH - January 28, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Orthopedics Suppliers Getting Stiff In JointsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
You'd think an aging population that wants to stay active and productive would mean a boom for makers of mechanical hip joints and knees. That's...
Source: Investor's Business Daily: HEALTH - January 24, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
FDA OKs Human Stem Cell Therapy TestEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Food and Drug Administration on Friday cleared the way for the first trial to see if human embryonic stem cells can treat people safely.
Source: Investor's Business Daily: HEALTH - January 23, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
A Week Of Bad News For Leading HMOsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
It was not the best of weeks for the nation's two biggest managed care insurers, or their industry.
Source: Investor's Business Daily: HEALTH - January 17, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Genentech Q4 Leaves Analysts CautiousEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Analysts maintained a cautious outlook on Genentech Friday, citing the biotech's pipeline potential and Roche's acquisition overtures but voicing...
Source: Investor's Business Daily: HEALTH - January 16, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Analyst: Details Count In Health Care StocksEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The U.S. health care sector accounted for more than 16% of gross domestic product in 2007. Total spending on health care was $2.2 trillion, or...
Source: Investor's Business Daily: HEALTH - January 14, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
While Street Sleeps, Amgen Stirs InterestEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Amgen's share price didn't budge a couple of weeks ago when it announced it had filed for regulatory approval of its osteoporosis biologic, denosumab.
Source: Investor's Business Daily: HEALTH - January 2, 2009 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Big Pharma Continues Its Assault On BiotechEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The rush by Big Pharma to muscle its way into biotechnology picked up more speed last week, with both Eli Lilly and AstraZeneca reportedly eyeing...
Source: Investor's Business Daily: HEALTH - December 27, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Allergan Gets Nod For Eyelash TreatmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Eye care and cosmetic drug maker Allergan on Friday said its eyelash growth treatment Latisse received Food and Drug Administration approval,...
Source: Investor's Business Daily: HEALTH - December 27, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Big Pharma Continues Its Assault On BiotechEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The rush by Big Pharma to muscle its way into biotechnology picked up more speed last week, with both Eli Lilly and AstraZeneca reportedly eyeing...
Source: Investor's Business Daily: HEALTH - December 27, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Allergan Gets Nod For Eyelash TreatmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Eye care and cosmetic drug maker Allergan on Friday said its eyelash growth treatment Latisse received Food and Drug Administration approval,...
Source: Investor's Business Daily: HEALTH - December 26, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Genzyme Gets A Lift With Latest FDA NodEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Wall Street's embrace of biotech stocks is as much about potential as anything else, the theory being that the best biotechs are busy developing...
Source: Investor's Business Daily: HEALTH - December 19, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Merck's Biotech Move Follows Pharma TrendEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Merck's plan to become a leader in biotech drugs and widen its footprint in emerging markets created plenty of buzz last week, underscoring the...
Source: Investor's Business Daily: HEALTH - December 13, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Elan Cutting Back Offices, Head CountEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The cost cutting comes as the company works to offset slower growth of its lead drug, Tysabri, and strengthen its balance sheet.
Source: Investor's Business Daily: HEALTH - December 12, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Pharma Readies Itself For Change In PowerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A big question mark hanging over the future of biopharma is the Obama administration's plans for the Food and Drug Administration.
Source: Investor's Business Daily: HEALTH - December 6, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Cubist Shares Retreat On DowngradeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Shares of Cubist Pharmaceuticals retreated from longtime highs on Friday after an Oppenheimer analyst downgraded the stock.
Source: Investor's Business Daily: HEALTH - December 5, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Biotech VC Funding Faces Tough MarketEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
You don't hear much about funding of young biotech companies these days. No wonder, given the state of the economy.
Source: Investor's Business Daily: HEALTH - November 29, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Lilly Delays New Application For CymbaltaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FROM IBD NEWS SERVICES
Source: Investor's Business Daily: HEALTH - November 28, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Sagging Share Prices Rock HMO IndustryEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Take a look at the recent stock performances of big health management firms, and it's easy to see why some experts wonder if it's time for the...
Source: Investor's Business Daily: HEALTH - November 22, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
AstraZeneca Treatment Gets Good ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Some advanced lung cancer patients already treated with chemotherapy might be able to skip some of the bad side effects of another series of chemo...
Source: Investor's Business Daily: HEALTH - November 21, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Pfizer Announces Plan For Stem Cell UnitEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FROM IBD NEWS SERVICES
Source: Investor's Business Daily: HEALTH - November 18, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Gains By Democrats Put Pharma On EdgeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
One of the clouds on Big Pharma's horizon is the prospect that the new Democratic regime will act to restrain drug prices.
Source: Investor's Business Daily: HEALTH - November 15, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Pfizer Announces Plan For Stem Cell UnitEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FROM IBD NEWS SERVICES
Source: Investor's Business Daily: HEALTH - November 14, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Genzyme, Osiris Eye Stem Cell-Based DrugsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
At last, there's evidence that some companies are getting close to commercializing stem cell science.
Source: Investor's Business Daily: HEALTH - November 8, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Tarceva Meets Goal In Lung Cancer TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
OSI Pharmaceuticals and Genentech on Friday said their drug Tarceva met its main goal in a clinical trial: stopping the spread of advanced...
Source: Investor's Business Daily: HEALTH - November 7, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Biogen Bounces Back, But Concerns RemainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Biogen Idec shares rebounded in midday trade Friday, a day after the biotech's stock tumbled on the news that a third multiple sclerosis patient...
Source: Investor's Business Daily: HEALTH - October 31, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
Diabetes News Could Boost Amylin, LillyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New medical industry treatment guidelines could give Eli Lilly and Amylin Pharmaceuticals' diabetes drug Byetta a boost as it continues to deal...
Source: Investor's Business Daily: HEALTH - October 27, 2008 Category: Pharmaceuticals Tags: Health & Medicine Source Type: info
